PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS
The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, resp...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others.
L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale. |
---|